Found 15 matching trials
Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC PHASE1 This study enrolls patients who have relapsed/advanced hepatocellular carci...
Show More Location
Beijing Youan Hospital,Capital Medical University
Learn More & Join Trial
Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy PHASE2 The goal of this clinical trial is to explore the efficacy and safety of au...
Show More Location
Beijing Youan Hospital,Capital Medical University
Learn More & Join Trial
Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid Tumor PHASE1 Invariant Natural killer T (iNKT) cells are a unique subset of lymphocytes ...
Show More Location
Shanghai Public Health Clinical Center, Fudan University
Learn More & Join Trial
Allogeneic iNKT Cell Therapy (agenT-797) After SCT PHASE1 The goal of this clinical trial is to learn if agenT-797 is safe to use on ...
Show More Location
University of Wisconsin - Madison
Learn More & Join Trial
In Vitro Expanded Autologous Invariant Natural Killer Cells in Cancer PHASE1 The purpose of this research study is to determine whether we can purify an...
Show More Location
Beth Israel Deaconess Medical Center
Learn More & Join Trial
Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors PHASE1 This study aims to evaluate the safety and feasibility of hCD19.IL15.CAR-iN...
Show More Location
The Affiliated hospital of Xuzhou medical University
Learn More & Join Trial
A Study Investigating agenT-797 in Participants With Relapsed/Refractory Solid Tumors PHASE1 This is a Phase 1, open-label study to explore the safety, tolerability, an...
Show More Location
University of Southern California
Learn More & Join Trial
A Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Allogeneic iNKT Cell Infusion in Subjects With Advanced Pancreatic Cancer NA To evaluate the preliminary safety and tolerability of iNKT cell injection ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Adoptive Transfer of iNKT Cells Combined With TAE/TACE to Treat Unresectable HCC PHASE2 Hepatocellular carcinoma (HCC) is a common disease with high mortality. Mor...
Show More Location
Beijing Youan Hospital,Capital Medical University
Learn More & Join Trial
agenT-797 in Participants With Relapsed/Refractory Multiple Myeloma PHASE1 This is a Phase 1, open-label study to explore the safety, tolerability, an...
Show More Location
Norton Cancer Institute - St. Matthews - Medical Oncology/Hematology Candida
Learn More & Join Trial